Small pharmas in 'non-stop crisis management'
The prices of the products of small Hungarian pharmaceutical manufacturers are one-third of the average pharmaceutical prices, a box of which costs an average of HUF 970, Tibor Ásványi, chairman of the SME Committee of the National Association of Hungarian Pharmaceutical Manufacturers, told business daily Világgazdaság.
These businesses are in non-stop and acute crisis management. These small and medium-sized enterprises account for 2% of the domestic drug supply, and one in 10 of the drugs they produce goes into the basket of domestic consumers.
Last year, their sales revenue exceeded HUF 22.1 billion, while in 2019, it was HUF 22.3 bln.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.